Commercial Support and Continuing Medical Education
- 10 February 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (6) , 534-535
- https://doi.org/10.1056/nejmp048322
Abstract
The majority of the financial support for continuing medical education (CME) in the United States comes from drug companies and other commercial entities (see graph).1 Total commercial support more than tripled between 1998 and 2003 — from $302 million to $971 million. CME should aim to improve health care and should be totally independent of commercial interests, but there are long-standing concerns that it often involves marketing as well as education.2 For example, about 100 accredited U.S. providers of CME are for-profit medical education and communication companies, or MECCs. They are hired by pharmaceutical firms to organize meetings, find speakers . . .Keywords
This publication has 0 references indexed in Scilit: